0001771706-26-000007.txt : 20260824 0001771706-26-000007.hdr.sgml : 20260824 20260824102147 ACCESSION NUMBER: 0001771706-26-000007 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260824 DATE AS OF CHANGE: 20260824 EFFECTIVENESS DATE: 20260824 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vireo Growth Inc. CENTRAL INDEX KEY: 0001771706 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-595099 FILM NUMBER: 261307145 BUSINESS ADDRESS: STREET 1: 207 SOUTH 9TH STREET CITY: MINNEAPOLIS STATE: MN ZIP: 55402 BUSINESS PHONE: 612-999-1606 MAIL ADDRESS: STREET 1: 207 SOUTH 9TH STREET CITY: MINNEAPOLIS STATE: MN ZIP: 55402 FORMER COMPANY: FORMER CONFORMED NAME: Goodness Growth Holdings, Inc. DATE OF NAME CHANGE: 20210607 FORMER COMPANY: FORMER CONFORMED NAME: Vireo Health International, Inc. DATE OF NAME CHANGE: 20190326 D 1 primary_doc.xml X0708 D LIVE 0001771706 Vireo Growth Inc. 207 SOUTH 9TH STREET MINNEAPOLIS MN MINNESOTA 55402 612-999-1606 BRITISH COLUMBIA, CANADA Darien Business Development Corp. Goodness Growth Holdings, Inc. Vireo Health International, Inc. Corporation true John Mazarakis 207 South 9th Street Minneapolis MN MINNESOTA 55402 Executive Officer Director Kyle Kingsley 207 South 9th Street Minneapolis MN MINNESOTA 55402 Director Judd Nordquist 207 South 9th Street Minneapolis MN MINNESOTA 55402 Director Ross Hussey 207 South 9th Street Minneapolis MN MINNESOTA 55402 Director Victor E. Mancebo 207 South 9th Street Minneapolis MN MINNESOTA 55402 Director Tyson Macdonald 207 South 9th Street Minneapolis MN MINNESOTA 55402 Executive Officer Michael Steiner 207 South 9th Street Minneapolis MN MINNESOTA 55402 Director Chris Hagedorn 207 South 9th Street Minneapolis MN MINNESOTA 55402 Director Other Decline to Disclose 06b false 2026-08-07 false true true true On the date that is nine (9) months after the Closing, the Shares Escrow Agent shall automatically release 61,728 Shares to Agent. true 0 48676969 47676969 1000000 The remaining $1,000,000 to be sold may be received upon the final resolution of any pending indemnification claim, in accordance with the terms of the Shares Escrow Agreement. false 27 0 0 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false Vireo Growth Inc. /s/ Tyson Macdonald Tyson Macdonald Chief Financial Officer 2026-08-24